Menu

Filtros : "Indexado na Base de dados PubMed" "FARMACOLOGIA" "Cardiovascular Research" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway (2011)

    Lima, Victor Vitorino; Giachini, Fernanda Regina Casagrande; Carneiro, Fernando Silva; Carvalho, Maria Helena Catelli de; Fortes, Zuleica Bruno; Webb, R. Clinton; Tostes, Rita C.

    Source: Cardiovascular Research. Unidades: ICB, FMRP

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      LIMA, Victor Vitorino et al. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway. Cardiovascular Research, v. 89, n. 3, p. 614-622, 2011Tradução . . Disponível em: https://doi.org/10.1093/cvr/cvq338. Acesso em: 07 set. 2024.

    • APA

      Lima, V. V., Giachini, F. R. C., Carneiro, F. S., Carvalho, M. H. C. de, Fortes, Z. B., Webb, R. C., & Tostes, R. C. (2011). O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway. Cardiovascular Research, 89( 3), 614-622. doi:10.1093/cvr/cvq338

    • NLM

      Lima VV, Giachini FRC, Carneiro FS, Carvalho MHC de, Fortes ZB, Webb RC, Tostes RC. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway [Internet]. Cardiovascular Research. 2011 ; 89( 3): 614-622.[citado 2024 set. 07 ] Available from: https://doi.org/10.1093/cvr/cvq338

    • Vancouver

      Lima VV, Giachini FRC, Carneiro FS, Carvalho MHC de, Fortes ZB, Webb RC, Tostes RC. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway [Internet]. Cardiovascular Research. 2011 ; 89( 3): 614-622.[citado 2024 set. 07 ] Available from: https://doi.org/10.1093/cvr/cvq338

  • Artigo de periodico

    Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation (2009)

    Ying, Zhekang; Giachini, Fernanda R. C.; Passaglia, Rita de Cássia Aleixo Tostes; Webb, Robert Clinton

    Source: Cardiovascular Research. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      YING, Zhekang et al. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation. Cardiovascular Research, v. 83, n. 1, p. 155-162, 2009Tradução . . Disponível em: https://doi.org/10.1093/cvr/cvp084. Acesso em: 07 set. 2024.

    • APA

      Ying, Z., Giachini, F. R. C., Passaglia, R. de C. A. T., & Webb, R. C. (2009). Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation. Cardiovascular Research, 83( 1), 155-162. doi:10.1093/cvr/cvp084

    • NLM

      Ying Z, Giachini FRC, Passaglia R de CAT, Webb RC. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation [Internet]. Cardiovascular Research. 2009 ; 83( 1): 155-162.[citado 2024 set. 07 ] Available from: https://doi.org/10.1093/cvr/cvp084

    • Vancouver

      Ying Z, Giachini FRC, Passaglia R de CAT, Webb RC. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation [Internet]. Cardiovascular Research. 2009 ; 83( 1): 155-162.[citado 2024 set. 07 ] Available from: https://doi.org/10.1093/cvr/cvp084
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024